Clinuvel Pharmaceuticals Ltd. | Ownership
Companies that own Clinuvel Pharmaceuticals Ltd.
Lagoda Investment Management LP
3,405,794
7.12%
-1,372,502
11.03%
07/02/2018
FIL Investment Management (Hong Kong) Ltd.
2,604,320
5.45%
-429,523
0.12%
08/31/2018
FIL Investment Management (Singapore) Ltd.
402,096
0.84%
-292,429
0.05%
05/31/2018
Dimensional Fund Advisors LP
63,172
0.13%
13,892
0%
04/30/2018
Smith & Williamson Investment Management LLP
30,441
0.06%
0
0%
08/31/2018
FIL Investment Advisors (UK) Ltd.
16,692
0.04%
-873
0%
03/31/2018
Wil Asset Management (Liechtenstein) AG
8,500
0.02%
0
4.37%
07/30/2018
Acadian Asset Management LLC
2,566
0.01%
0
0%
06/30/2018
McKinley Capital Management LLC
0
0%
-1,906
0%
08/31/2018
| Address |
15 Queen Street
Melbourne Victoria (VIC) 3000
Australia
|
|
Employees
|
- |
| Website |
http://www.clinuvel.com |
| Updated |
07/08/2019 |
| Clinuvel Pharmaceuticals Ltd. is a global biopharmaceutical company. It engages in the the development of SCENESSE, its proprietary photoprotective drug. It also offers drugs for the treatment of various skin disorders. |
